| Literature DB >> 26762629 |
Martijn W J Stommel1, Johannes H W de Wilt2, Richard P G ten Broek2, Chema Strik2, Maroeska M Rovers3, Harry van Goor2.
Abstract
BACKGROUND: Prior abdominal surgery increases complexity of abdominal operations. Effort to prevent injury during adhesiolysis might result in less extensive bowel resection in colorectal cancer surgery. The aim of this study was to evaluate the effect of prior abdominal surgery on the outcome of colorectal cancer surgery.Entities:
Mesh:
Year: 2016 PMID: 26762629 PMCID: PMC4820482 DOI: 10.1007/s00268-015-3390-0
Source DB: PubMed Journal: World J Surg ISSN: 0364-2313 Impact factor: 3.352
Baseline characteristics Cohort 2010–2012
| Prior abdominal operations | Yes ( | No ( |
|
|---|---|---|---|
| Age | 71.3 (±10.8) | 68.4 (±11.3) | <0.001 |
| Sex (%) | 41.9 % male | 61.3 % male | <0.001 |
| ASA (%) | |||
| I | 15.5 | 23.0 | <0.001 |
| II | 58.2 | 55.1 | |
| III | 24.8 | 20.0 | |
| IV | 1.5 | 1.8 | |
| V | 0.1 | 0.1 | |
| Urgency operation (%) | |||
| Elective | 85.9 | 83.8 | <0.001 |
| Elective after stent placement | 0.7 | 0.6 | |
| Urgent | 7.4 | 8.0 | |
| Emergency | 5.9 | 7.5 | |
| Unknown | 0.2 | 0.1 | |
| Tumor localization (%) | |||
| Caecum | 15.9 | 13.3 | <0.001 |
| Appendix | 0.8 | 0.4 | |
| Ascending colon | 14.6 | 12.4 | |
| Hepatic flexure | 4.8 | 4.4 | |
| Transverse colon | 6.6 | 5.0 | |
| Splenic flexure | 2.3 | 2.4 | |
| Descending colon | 4.7 | 4.3 | |
| Sigmoid colon | 25.3 | 28.8 | |
| Rectum | 24.9 | 29.0 | |
| Neoadjuvant Therapy (%) (rectal cancer, | N = 1921 |
| 0.26 |
| No | 3.4 | 2.7 | |
| Short course | 55.2 | 54.1 | |
| Long course | 5.9 | 5.8 | |
| Chemoradiation | 35.5 | 37.4 | |
| Operation technique (%) | |||
| Open | 60.6 | 54.2 | <0.001 |
| Laparoscopic | 39. 4 | 45.8 | |
| Conversion in laparoscopy ( | |||
| No | 76.5 | 82.6 | <0.001 |
| Early (<30 min) | 12.5 | 8.5 | |
| Late (>30 min) | 11.1 | 9.0 | |
| Reason for conversion % | |||
| ( | <0.001 | ||
| Advanced tumor | 14.3 | 26.9 | |
| Accessibility | 79.1 | 65.4 | |
| Peroperative complication | 6.7 | 7.7 | |
| Type of resection % | |||
| Ileocaecal | 1.1 | 0.9 | <0.001 |
| Resection/appendicectomy | 36.1 | 30.7 | |
| Right hemicolectomy | 2.7 | 1.9 | |
| Transverse colectomy | 7.8 | 7.7 | |
| Left hemicolectomy | 40.6 | 47.3 | |
| (Low)Anterior | 1.7 | 1.4 | |
| Resection/sigmoidectomy | 7.6 | 8.5 | |
| Subtotal colectomy | 0.8 | 0.6 | |
| Abdominoperineal Resection | 1.4 | 1.0 | |
| Proctocolectomy | |||
| Other | |||
| T stage (pathol) (%) | |||
| 1 | 7.1 | 6.1 | 0.001 |
| 2 | 20.8 | 19.6 | |
| 3 | 55.7 | 57.6 | |
| 4 | 13.0 | 13.5 | |
| X | 2.1 | 1.8 | |
| 0 | 1.3 | 1.4 | |
| N stage (pathol) % | |||
| 0 | 60.3 | 57.5 | <0.001 |
| 1 | 24.3 | 25.4 | |
| 2 | 13.8 | 16.1 | |
| X | 1.6 | 1.0 | |
Histopathological and clinical outcome, cohort 2010–2012
| Prior abdominal operations | No prior abdominal operations | Crude OR/mean difference (95 % CI) | Adjusted OR/mean difference (95 % CI)a | |
|---|---|---|---|---|
| Number of lymph nodes | 15.2 | 15.6 | 0.39 (0.11–0.66)* | 0.37 (0.14–0.60)* |
| Colon cancer | 16.1 | 16.6 | 0.55 (0.200.90)* | 0.43 (0.15–0.71)* |
| Rectal cancer | 12.5 | 13.0 | 0.46 (0.11–0.81)* | 0.14 (−0.23 to 0.50) |
| <10 Lymph nodes (% pts) | 20.7 | 17.8 | 1.20 (1.13–1.28)* | 1.17 (1.09–1.26)* |
| Colon cancer | 16.5 | 13.4 | 1.28 (1.18–1.39)* | 1.22 (1.11–1.33)* |
| Rectal cancer | 32.9 | 28.7 | 1.22 (1.10–1.36)* | 1.09 (0.96–1.23) |
| <12 Lymph nodes (% pts) | 35.8 | 32.8 | 1.14 (1.08–1.20)* | 1.10 (1.04–1.17)* |
| Colon cancer | 30.7 | 27.6 | 1.16 (1.09–1.24)* | 1.10 (1.02–1.18)* |
| Rectal cancer | 50.8 | 45.6 | 1.23 (1.11–1.36)* | 1.11 (0.99–1.24) |
| Incomplete resection colon cancer (% pts) | 3.3 | 3.8 | 0.87 (0.73–1.02) | 0.92 (0.77–1.11) |
| Circumferential rectal resection margin (mm) | 11.0 | 11.1 | 0.111 (−0.56 to 0.77) | 0.10 (−0.82 to 1.02) |
| CRM positivity (% pts) | 10.2 | 9.1 | 1.14 (0.94–1.38) | 1.12 (0.90–1.40) |
| Complications (% pts) | 34.5 | 32.1 | 1.11 (1.05–1.17)* | 1.14 (1.07–1.21)* |
| Colon cancer | 33.2 | 29.7 | 1.17 (1.10–1.25)* | 1.18 (1.10–1.26)* |
| Rectal cancer | 38.0 | 37.9 | 1.01 (0.91–1.11) | 1.04 (0.92–1.17) |
| 30-day Mortality (% pts) | 4.7 | 3.8 | 1.24 (1.09–1.40)* | 1.01 (0.88–1.17) |
| Colon cancer | 5.3 | 4.3 | 1.24 (1.08–1.42)* | 1.01 (0.86–1.18) |
| Rectal cancer | 2.7 | 2.6 | 1.04 (0.76–1.41) | 1.02 (0.70–1.47) |
* P < 0.05
aAdjusted for male sex, age, ASA fitness grade, type of surgical resection, T stage at histopathology, N stage at histopathology, urgency of surgery, operation technique and neoadjuvant chemotherapy
bMissing data excluded per analysis
Histopathological outcome after colon cancer surgery according to type of prior abdominal surgery, cohort 2011–2012
| Prior colorectal operations | No prior abdominal operations | Crude OR/mean difference (95 % CI) | Adjusted OR/mean difference (95 % CI)a | |
|---|---|---|---|---|
| Number of lymph nodes | 16.3 | 17.1 | 0.80 (0.33–1.27)* | 0.61 (0.14–1.08)* |
| <10 lymph nodes (% pts) | 14.2 | 11.9 | 1.23 (1.06–1.42)* | 1.11 (0.94–1.30) |
| <12 lymph nodes (% pts) | 28.9 | 25.5 | 1.19 (1.06–1.33)* | 1.12 (1.00–1.27)** |
| Incomplete resection (% pts) | 6.2 | 3.8 | 1.66 (1.14–2.42)* | 1.30 (0.90–1.89) |
aAdjusted for male sex, age, ASA fitness grade, type of surgical resection, T stage at histopathology, N stage at histopathology, urgency of surgery, operation technique and neoadjuvant chemotherapy
bMissing data excluded per analysis
* P < 0.05
** P = 0.058
Histopathological outcome after rectal cancer surgery according to type of prior abdominal surgery, cohort 2011–2012
| Prior colorectal operations | No prior abdominal operations | Crude OR/mean difference (95 % CI) | Adjusted OR/mean difference (95 % CI)a | |
|---|---|---|---|---|
| Number of lymph nodes | 12.8 | 13.3 | 0.42 (−0.19 to 1.03) | 0.22 (−0.41 to 0.85) |
| <10 lymph nodes (% pts) | 30.4 | 26.2 | 1.23 (1.02–1.49)* | 1.11 (0.89–1.38) |
| <12 lymph nodes (% pts) | 47.4 | 43.9 | 1.15 (0.97–1.37) | 1.03 (0.84–1.25) |
| Circumferential margin (mm) | 10.0 | 10.8 | 0.83 (−0.12 to 1.77) | 0.64 (−0.37 to 1.65) |
| CRM positivity (% pts) | 12.5 | 7.6 | 1.74 (1.29–2.33)* | 1.70 (1.21–2.39)* |
aAdjusted for male sex, age, ASA fitness grade, type of surgical resection, T stage at histopathology, N stage at histopathology, urgency of surgery, operation technique and neoadjuvant chemotherapy
bMissing data excluded per analysis
* P < 0.05